Plasma Metabolomics for Discovery of Early Metabolic Markers of Prostate Cancer Based on Ultra-High-Performance Liquid Chromatography-High Resolution Mass Spectrometry — Xiangping Lin (2021) | RDL Network
Plasma Metabolomics for Discovery of Early Metabolic Markers of Prostate Cancer Based on Ultra-High-Performance Liquid Chromatography-High Resolution Mass Spectrometry
Article 2021 en
Authors
XL
Xiangping Lin
LL
Lucie Lécuyer
XL
Xinyu Liu
Abstract
1 min read
Our results support the dysregulation of amino acids and sphingolipid metabolism during the development of PCa. After validation in an independent cohort, these signatures may promote the development of new prevention and screening strategies to identify males at future risk of PCa.
P. Martijn Kolijn, Karl Smith-Byrne, Vernon A. Burk, Vivian Viallon, Matthew A. Lee, Keren Papier, Ziqiao Wang, Anton W. Langerak, Florentin Späth, Arjan Diepstra, Christina M. Lill, Alessandra Macciotta, Amaia Aizpurua, Rosario Tumino, Nilanjan Chatterjee, Ruth C. Travis, Marc J. Gunter, Elizabeth A. Platz, Elio Riboli, James McKay, Roel Vermeulen
Zhe Huang, Mahboubeh Parsaeian, Vivian Viallon, Ziqiao Wang, Keren Papier, Trishna Desai, Stephanie Chan, Antonio Agudo, Carlotta Sacerdote, David C. Muller, Domenico Pali, Giovanna Masala, Nicholas J. Wareham, Raúl Zamora‐Ros, Roel Vermeulen, Rosario Tumino, Ian G. Mills, Nilanjan Chatterjee, Elizabeth A. Platz, Pietro Ferrari, Marc J. Gunter, Elio Riboli, Timothy J. Key, Joshua Atkins,
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.